DK0575429T3 - Behandlings af kognitive lidelser - Google Patents

Behandlings af kognitive lidelser

Info

Publication number
DK0575429T3
DK0575429T3 DK92906578.7T DK92906578T DK0575429T3 DK 0575429 T3 DK0575429 T3 DK 0575429T3 DK 92906578 T DK92906578 T DK 92906578T DK 0575429 T3 DK0575429 T3 DK 0575429T3
Authority
DK
Denmark
Prior art keywords
treatment
cognitive disorders
patient
compound
formula
Prior art date
Application number
DK92906578.7T
Other languages
English (en)
Inventor
Jens Kristian Perregaard
Brenda Costall
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of DK0575429T3 publication Critical patent/DK0575429T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Processing Of Meat And Fish (AREA)
DK92906578.7T 1991-03-01 1992-02-28 Behandlings af kognitive lidelser DK0575429T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK036291A DK36291D0 (da) 1991-03-01 1991-03-01 Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser

Publications (1)

Publication Number Publication Date
DK0575429T3 true DK0575429T3 (da) 1996-04-22

Family

ID=8092662

Family Applications (2)

Application Number Title Priority Date Filing Date
DK036291A DK36291D0 (da) 1991-03-01 1991-03-01 Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser
DK92906578.7T DK0575429T3 (da) 1991-03-01 1992-02-28 Behandlings af kognitive lidelser

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK036291A DK36291D0 (da) 1991-03-01 1991-03-01 Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser

Country Status (17)

Country Link
US (1) US5444073A (da)
EP (1) EP0575429B1 (da)
JP (1) JP3108434B2 (da)
KR (1) KR0183424B1 (da)
AT (1) ATE131055T1 (da)
AU (1) AU663699B2 (da)
CA (1) CA2105385C (da)
CY (1) CY2083B1 (da)
DE (1) DE69206607T2 (da)
DK (2) DK36291D0 (da)
HK (1) HK1003560A1 (da)
IE (1) IE70600B1 (da)
IL (1) IL101102A (da)
NO (1) NO307406B1 (da)
NZ (1) NZ241800A (da)
WO (1) WO1992015303A1 (da)
ZA (1) ZA921462B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
US6489341B1 (en) 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
EP2295061A1 (en) 2002-08-22 2011-03-16 Dainippon Sumitomo Pharma Co., Ltd. Agent for treatment of schizophrenia
WO2004113333A1 (ja) * 2003-06-23 2004-12-29 Dainippon Sumitomo Pharma Co., Ltd. 老人性痴呆症治療剤
EP2357474A1 (en) 2004-02-20 2011-08-17 Dainippon Sumitomo Pharma Co., Ltd. Lurasidone for use in the treatment of memory or learning dysfunction by schizophrenia
US20070212412A1 (en) * 2005-09-08 2007-09-13 H. Lundbeck A/S Stable solid formulation of sertindole
TW200821296A (en) * 2006-06-01 2008-05-16 Lundbeck & Co As H Use of sertindole for the preventive treatment of suicidal behaviour
US8258139B2 (en) 2010-11-08 2012-09-04 Dainippon Sumitomo Pharma Co., Ltd. Method of treatment for mental disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48508A (en) * 1974-12-09 1979-10-31 Roussel Uclaf Pharmaceutical compositions comprising piperidylindole derivatives
FR2362628A1 (fr) * 1976-08-26 1978-03-24 Roussel Uclaf Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments
SE8004129L (sv) * 1979-07-13 1981-01-14 Roussel Uclaf Nya tetrahydropyridin-4-yl-indolderivat samt salter derav, framstellning och anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8704572D0 (en) * 1987-02-26 1987-04-01 Lundbeck & Co As H Organic compounds
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater

Also Published As

Publication number Publication date
IE70600B1 (en) 1996-12-11
DE69206607D1 (de) 1996-01-18
US5444073A (en) 1995-08-22
CY2083B1 (en) 1998-10-16
JP3108434B2 (ja) 2000-11-13
DE69206607T2 (de) 1996-05-15
NO933091L (no) 1993-11-01
IL101102A (en) 1996-03-31
WO1992015303A1 (en) 1992-09-17
EP0575429A1 (en) 1993-12-29
KR930702978A (ko) 1993-11-29
IL101102A0 (en) 1992-11-15
NZ241800A (en) 1997-03-24
CA2105385A1 (en) 1992-09-02
ZA921462B (en) 1992-11-25
EP0575429B1 (en) 1995-12-06
HK1003560A1 (en) 1998-10-30
JPH06504787A (ja) 1994-06-02
KR0183424B1 (ko) 1999-05-01
ATE131055T1 (de) 1995-12-15
NO933091D0 (no) 1993-08-31
DK36291D0 (da) 1991-03-01
CA2105385C (en) 2000-08-15
AU1370792A (en) 1992-10-06
NO307406B1 (no) 2000-04-03
AU663699B2 (en) 1995-10-19
IE920572A1 (en) 1992-09-09

Similar Documents

Publication Publication Date Title
MY117896A (en) Quinazoline derivatives
NO974163D0 (no) Ester av 5-aminolevulinsyre som fotosensibiliserings-middel i fotokjemoterapi
FI102964B1 (fi) Terapeuttisia yhdisteitä
DK0575429T3 (da) Behandlings af kognitive lidelser
ES2053668T3 (es) Derivados de poliamina como agentes antineoplasicos.
ES8605507A1 (es) Un compuesto de 3-indolcarboxamida
DK0583271T3 (da) Arylmorpholin, fremstilling og anvendelse
ATE152708T1 (de) (1,2n) und (3,2n)-karbozyklische-2-amino- tetralinderivate
HU9400908D0 (en) Pharmaceutical compositions for treatng skin disorders
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
DE69526452D1 (de) Indolditerpen alkaloide
MY133438A (en) Morpholinobenzamide salts
PT1082116E (pt) Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento
ATE135217T1 (de) Pharmazeutische zusammensetzungen zur aids- behandlung
SE8302452D0 (sv) Method for treatment of senile dementia
ES501744A0 (es) Procedimiento para la obtencion de bis (fenoxiacetatos sus- tituidos)de n-alcohil-dialcanolaminas
IT1245631B (it) Impiego di composti macrolidi come agenti anti-infiammatori per il trattamento di malattie provocate da cessione di istamina